Nateglinide + troglitazone: additive benefits in type II diabetes

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2002

Schlagwörter:	Fast Plasma Glucose Additive Benefit Thiazolidinedione Troglitazone Fast Plasma Glucose Level

Anmerkung:	© Adis International Ltd 2002

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1362(2002), 1 vom: Nov., Seite 12-12
Übergeordnetes Werk:	volume:1362 ; year:2002 ; number:1 ; month:11 ; pages:12-12

Links:	Volltext

DOI / URN:	10.2165/00128413-200213620-00022

Katalog-ID:	SPR035142405

Internformat


LEADER	01000caa a22002652 4500
001	SPR035142405
003	DE-627
005	20230519230228.0
007	cr uuu---uuuuu
008	201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200213620-00022 \|2 doi
035			\|a (DE-627)SPR035142405
035			\|a (SPR)00128413-200213620-00022-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Nateglinide + troglitazone: additive benefits in type II diabetes
264		1	\|c 2002
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2002
650		4	\|a Fast Plasma Glucose \|7 (dpeaa)DE-He213
650		4	\|a Additive Benefit \|7 (dpeaa)DE-He213
650		4	\|a Thiazolidinedione \|7 (dpeaa)DE-He213
650		4	\|a Troglitazone \|7 (dpeaa)DE-He213
650		4	\|a Fast Plasma Glucose Level \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1362(2002), 1 vom: Nov., Seite 12-12 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1362 \|g year:2002 \|g number:1 \|g month:11 \|g pages:12-12
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200213620-00022 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1362 \|j 2002 \|e 1 \|c 11 \|h 12-12

Indexfelder

matchkey_str	article:22306056:2002----::aelndtoltznadtvbnft
hierarchy_sort_str	2002
publishDate	2002
allfields	10.2165/00128413-200213620-00022 doi (DE-627)SPR035142405 (SPR)00128413-200213620-00022-e DE-627 ger DE-627 rakwb eng Nateglinide + troglitazone: additive benefits in type II diabetes 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Fast Plasma Glucose (dpeaa)DE-He213 Additive Benefit (dpeaa)DE-He213 Thiazolidinedione (dpeaa)DE-He213 Troglitazone (dpeaa)DE-He213 Fast Plasma Glucose Level (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1362(2002), 1 vom: Nov., Seite 12-12 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1362 year:2002 number:1 month:11 pages:12-12 https://dx.doi.org/10.2165/00128413-200213620-00022 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1362 2002 1 11 12-12
spelling	10.2165/00128413-200213620-00022 doi (DE-627)SPR035142405 (SPR)00128413-200213620-00022-e DE-627 ger DE-627 rakwb eng Nateglinide + troglitazone: additive benefits in type II diabetes 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Fast Plasma Glucose (dpeaa)DE-He213 Additive Benefit (dpeaa)DE-He213 Thiazolidinedione (dpeaa)DE-He213 Troglitazone (dpeaa)DE-He213 Fast Plasma Glucose Level (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1362(2002), 1 vom: Nov., Seite 12-12 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1362 year:2002 number:1 month:11 pages:12-12 https://dx.doi.org/10.2165/00128413-200213620-00022 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1362 2002 1 11 12-12
allfields_unstemmed	10.2165/00128413-200213620-00022 doi (DE-627)SPR035142405 (SPR)00128413-200213620-00022-e DE-627 ger DE-627 rakwb eng Nateglinide + troglitazone: additive benefits in type II diabetes 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Fast Plasma Glucose (dpeaa)DE-He213 Additive Benefit (dpeaa)DE-He213 Thiazolidinedione (dpeaa)DE-He213 Troglitazone (dpeaa)DE-He213 Fast Plasma Glucose Level (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1362(2002), 1 vom: Nov., Seite 12-12 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1362 year:2002 number:1 month:11 pages:12-12 https://dx.doi.org/10.2165/00128413-200213620-00022 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1362 2002 1 11 12-12
allfieldsGer	10.2165/00128413-200213620-00022 doi (DE-627)SPR035142405 (SPR)00128413-200213620-00022-e DE-627 ger DE-627 rakwb eng Nateglinide + troglitazone: additive benefits in type II diabetes 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Fast Plasma Glucose (dpeaa)DE-He213 Additive Benefit (dpeaa)DE-He213 Thiazolidinedione (dpeaa)DE-He213 Troglitazone (dpeaa)DE-He213 Fast Plasma Glucose Level (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1362(2002), 1 vom: Nov., Seite 12-12 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1362 year:2002 number:1 month:11 pages:12-12 https://dx.doi.org/10.2165/00128413-200213620-00022 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1362 2002 1 11 12-12
allfieldsSound	10.2165/00128413-200213620-00022 doi (DE-627)SPR035142405 (SPR)00128413-200213620-00022-e DE-627 ger DE-627 rakwb eng Nateglinide + troglitazone: additive benefits in type II diabetes 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Fast Plasma Glucose (dpeaa)DE-He213 Additive Benefit (dpeaa)DE-He213 Thiazolidinedione (dpeaa)DE-He213 Troglitazone (dpeaa)DE-He213 Fast Plasma Glucose Level (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1362(2002), 1 vom: Nov., Seite 12-12 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1362 year:2002 number:1 month:11 pages:12-12 https://dx.doi.org/10.2165/00128413-200213620-00022 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1362 2002 1 11 12-12
language	English
source	Enthalten in Inpharma weekly 1362(2002), 1 vom: Nov., Seite 12-12 volume:1362 year:2002 number:1 month:11 pages:12-12
sourceStr	Enthalten in Inpharma weekly 1362(2002), 1 vom: Nov., Seite 12-12 volume:1362 year:2002 number:1 month:11 pages:12-12
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Fast Plasma Glucose Additive Benefit Thiazolidinedione Troglitazone Fast Plasma Glucose Level
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2002-11-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035142405
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035142405</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519230228.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200213620-00022</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035142405</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200213620-00022-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nateglinide + troglitazone: additive benefits in type II diabetes</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2002</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Fast Plasma Glucose</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Additive Benefit</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Thiazolidinedione</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Troglitazone</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Fast Plasma Glucose Level</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1362(2002), 1 vom: Nov., Seite 12-12</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1362</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">month:11</subfield><subfield code="g">pages:12-12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200213620-00022</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1362</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="c">11</subfield><subfield code="h">12-12</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Nateglinide + troglitazone: additive benefits in type II diabetes Fast Plasma Glucose (dpeaa)DE-He213 Additive Benefit (dpeaa)DE-He213 Thiazolidinedione (dpeaa)DE-He213 Troglitazone (dpeaa)DE-He213 Fast Plasma Glucose Level (dpeaa)DE-He213
topic	misc Fast Plasma Glucose misc Additive Benefit misc Thiazolidinedione misc Troglitazone misc Fast Plasma Glucose Level
spellingShingle	misc Fast Plasma Glucose misc Additive Benefit misc Thiazolidinedione misc Troglitazone misc Fast Plasma Glucose Level Nateglinide + troglitazone: additive benefits in type II diabetes
topic_unstemmed	misc Fast Plasma Glucose misc Additive Benefit misc Thiazolidinedione misc Troglitazone misc Fast Plasma Glucose Level
topic_browse	misc Fast Plasma Glucose misc Additive Benefit misc Thiazolidinedione misc Troglitazone misc Fast Plasma Glucose Level
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Nateglinide + troglitazone: additive benefits in type II diabetes
ctrlnum	(DE-627)SPR035142405 (SPR)00128413-200213620-00022-e
title_full	Nateglinide + troglitazone: additive benefits in type II diabetes
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2002
contenttype_str_mv	txt
container_start_page	12
container_volume	1362
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200213620-00022
title_sort	nateglinide + troglitazone: additive benefits in type ii diabetes
title_auth	Nateglinide + troglitazone: additive benefits in type II diabetes
abstract	© Adis International Ltd 2002
abstractGer	© Adis International Ltd 2002
abstract_unstemmed	© Adis International Ltd 2002
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Nateglinide + troglitazone: additive benefits in type II diabetes
url	https://dx.doi.org/10.2165/00128413-200213620-00022
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200213620-00022
up_date	2024-07-03T13:44:00.936Z
_version_	1803565652708950016
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035142405</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519230228.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200213620-00022</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035142405</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200213620-00022-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nateglinide + troglitazone: additive benefits in type II diabetes</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2002</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Fast Plasma Glucose</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Additive Benefit</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Thiazolidinedione</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Troglitazone</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Fast Plasma Glucose Level</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1362(2002), 1 vom: Nov., Seite 12-12</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1362</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">month:11</subfield><subfield code="g">pages:12-12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200213620-00022</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1362</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="c">11</subfield><subfield code="h">12-12</subfield></datafield></record></collection>
score	7.4020653

Nicht das Richtige dabei?

Schreiben Sie uns!

Nateglinide + troglitazone: additive benefits in type II diabetes

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?